Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$110.31 - $140.45 $3,860 - $4,915
-35 Reduced 0.84%
4,133 $468,000
Q1 2024

May 08, 2024

BUY
$114.22 - $140.1 $224,670 - $275,576
1,967 Added 89.37%
4,168 $578,000
Q4 2023

Feb 08, 2024

SELL
$75.49 - $124.16 $3,925 - $6,456
-52 Reduced 2.31%
2,201 $273,000
Q3 2023

Nov 07, 2023

SELL
$86.06 - $137.93 $25,990 - $41,654
-302 Reduced 11.82%
2,253 $210,000
Q1 2023

May 10, 2023

SELL
$104.0 - $122.92 $13,728 - $16,225
-132 Reduced 4.91%
2,555 $296,000
Q4 2022

Feb 09, 2023

SELL
$84.98 - $122.67 $1,699 - $2,453
-20 Reduced 0.74%
2,687 $304,000
Q3 2022

Nov 09, 2022

SELL
$76.35 - $94.18 $381 - $470
-5 Reduced 0.18%
2,707 $218,000
Q2 2022

Aug 09, 2022

BUY
$67.99 - $132.89 $134,416 - $262,723
1,977 Added 268.98%
2,712 $202,000
Q1 2022

May 06, 2022

SELL
$94.08 - $130.2 $14,676 - $20,311
-156 Reduced 17.51%
735 $376,000
Q4 2021

Feb 09, 2022

SELL
$129.87 - $162.82 $25,714 - $32,238
-198 Reduced 18.18%
891 $478,000
Q3 2021

Nov 09, 2021

SELL
$106.71 - $143.18 $119,621 - $160,504
-1,121 Reduced 50.72%
1,089 $596,000
Q2 2021

Aug 11, 2021

SELL
$80.99 - $107.93 $568,954 - $758,208
-7,025 Reduced 76.07%
2,210 $944,000
Q1 2021

May 03, 2021

BUY
$84.79 - $104.74 $301,089 - $371,931
3,551 Added 62.47%
9,235 $3.32 Million
Q4 2020

Feb 09, 2021

BUY
$78.0 - $104.5 $379,626 - $508,601
4,867 Added 595.72%
5,684 $2.1 Million
Q3 2020

Nov 04, 2020

BUY
$95.51 - $112.95 $1,719 - $2,033
18 Added 2.25%
817 $337,000
Q2 2020

Aug 07, 2020

SELL
$62.68 - $105.34 $9,276 - $15,590
-148 Reduced 15.63%
799 $324,000
Q1 2020

May 08, 2020

SELL
$47.79 - $75.63 $11,469 - $18,151
-240 Reduced 20.22%
947 $255,000
Q4 2019

Feb 07, 2020

SELL
$36.62 - $57.29 $41,563 - $65,024
-1,135 Reduced 48.88%
1,187 $260,000
Q3 2019

Nov 06, 2019

SELL
$35.53 - $43.8 $11,547 - $14,234
-325 Reduced 12.28%
2,322 $347,000
Q2 2019

Aug 05, 2019

BUY
$27.84 - $38.92 $11,219 - $15,684
403 Added 17.96%
2,647 $397,000
Q1 2019

May 07, 2019

BUY
$28.07 - $38.18 $62,989 - $85,675
2,244 New
2,244 $267,000
Q4 2018

Feb 13, 2019

SELL
$26.99 - $37.37 $45,856 - $63,491
-1,699 Closed
0 $0
Q3 2018

Nov 30, 2018

BUY
$23.35 - $36.72 $39,671 - $62,387
1,699 New
1,699 $243,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.